[HTML][HTML] Role of glycosyltransferases in carcinogenesis; growth factor signaling and EMT/MET programs

M Takahashi, Y Hasegawa, K Maeda, M Kitano… - Glycoconjugate …, 2022 - Springer
The glycosylation of cell surface receptors has been shown to regulate each step of signal
transduction, including receptor trafficking to the cell surface, ligand binding, dimerization …

Disease-associated glycans on cell surface proteins

M Takahashi, Y Kizuka, K Ohtsubo, J Gu… - Molecular aspects of …, 2016 - Elsevier
Most of membrane molecules including cell surface receptors and secreted proteins
including ligands are glycoproteins and glycolipids. Therefore, identifying the functional …

Analysis of carbohydrates and glycoconjugates by matrix‐assisted laser desorption/ionization mass spectrometry: An update for 2013–2014

DJ Harvey - Mass Spectrometry Reviews, 2018 - Wiley Online Library
This review is the eighth update of the original article published in 1999 on the application of
Matrix‐assisted laser desorption/ionization mass spectrometry (MALDI) mass spectrometry …

[HTML][HTML] Mechanisms of receptor tyrosine-protein kinase ErbB-3 (ERBB3) action in human neoplasia

LE Black, JF Longo, SL Carroll - The American Journal of Pathology, 2019 - Elsevier
It is well established that the epidermal growth factor (EGF) receptor, receptor tyrosine-
protein kinase erbB-2 (ERBB2)/human EGF receptor 2 (HER2), and, to a lesser extent …

Surfactant protein D suppresses lung cancer progression by downregulation of epidermal growth factor signaling

Y Hasegawa, M Takahashi, S Ariki, D Asakawa… - Oncogene, 2015 - nature.com
Abstract Surfactant protein D (SP-D) is a member of the collectin family that has an important
role in maintaining pulmonary homeostasis. In this study, we demonstrated that SP-D …

N‐glycosylation regulates MET processing and signaling

A Saitou, Y Hasegawa, N Fujitani, S Ariki… - Cancer …, 2022 - Wiley Online Library
MET, the receptor for the hepatocyte growth factor (HGF), is strongly associated with
resistance to tyrosine kinase inhibitors, key drugs that are used in the therapy of non–small …

Site-specific glycosylation analysis of epidermal growth factor receptor 2 (ErbB2): exploring structure and function toward therapeutic targeting

N Fujitani, Y Uehara, S Ariki, U Hashimoto… - …, 2024 - academic.oup.com
Glycans found on receptor tyrosine kinases (RTKs) have emerged as promising targets for
cancer chemotherapy, aiming to address issues such as drug resistance. However, to …

N-glycans of growth factor receptors: their role in receptor function and disease implications

M Takahashi, Y Hasegawa, C Gao, Y Kuroki… - Clinical …, 2016 - portlandpress.com
Numerous signal-transduction-related molecules are secreted proteins or membrane
proteins, and the mechanism by which these molecules are regulated by glycan chains is a …

[HTML][HTML] N-glycan on N262 of FGFR3 regulates the intracellular localization and phosphorylation of the receptor

U Hashimoto, N Fujitani, Y Uehara, H Okamoto… - … et Biophysica Acta (BBA …, 2024 - Elsevier
N-glycosylation and proper processing of N-glycans are required for the function of
membrane proteins including cell surface receptors. Fibroblast growth factor receptor …

Surfactant protein D inhibits activation of non-small cell lung cancer-associated mutant EGFR and affects clinical outcomes of patients

Y Umeda, Y Hasegawa, M Otsuka, S Ariki, R Takamiya… - Oncogene, 2017 - nature.com
Tyrosine kinase inhibitor (TKI)-sensitive and TKI-resistant mutations of epidermal growth
factor receptor (EGFR) are associated with lung adenocarcinoma. EGFR mutants were …